Nicolas Favre, PhD MBA

Chief Business Officer at Debiopharm, Head of Business, Commercial, and Program Leadership & Management

Lausanne, Vaud, Switzerland

About

With over 25 years in the pharmaceutical industry, including more than 20 years of commercial and business expertise, I focus on advancing oncology solutions as Chief Business Officer at Debiopharm. My mission is to guide a talented and diverse team in developing impactful strategies, fostering external partnerships, and driving pipeline innovation to maximize patient outcomes. At Debiopharm, I contribute to business development, commercial management, and program leadership, leveraging expertise in oncology to create valuable collaborations with pharmaceutical leaders. My work is centered on integrating market insights to enhance strategic decision-making and deliver meaningful growth and innovation to our pipeline while ensuring our developments become and stay relevant to patients and our partners.

Experience

  • Debiopharm (10 yrs 5 mos)
    • Chief Business Officer
      Dec 2023 - Present · 2 yrs 7 mos

    • Senior Executive Director, Business Develoment & Commercial
      Dec 2021 - Dec 2023 · 2 yrs 1 mo

    • Executive Director, Head of Marketing, Market Access & Medical Affairs
      Jan 2020 - Dec 2021 · 2 yrs

  • Senior Global Product Manager, Levemir at Novo Nordisk
    May 2013 - Jan 2016 · 2 yrs 9 mos

    Responsible for new global strategy launched globally. Business partner for US and Central European markets. Drive Global Brand planning.

  • Global Brand Manager, Azilect at Lundbeck
    Mar 2011 - Apr 2013 · 2 yrs 2 mos

    Responsible of annual global product strategy plan, patient relations and product-related market research projects Business partner for Eastern European region affiliates Commercial responsible for an end-phase I product

  • Brand Institute (2 yrs 3 mos)
    • President, Brand Development - Geneva
      Sep 2009 - Mar 2011 · 1 yr 7 mos

      Responsible of brand name development of 12 new drugs and medical devices for Sanofi, Novartis, IPSEN, Roche, Novo Nordisk, Servier in diabetes, oncology, autoimmune diseases and depression Led product positioning and brand identity development of 5 new drugs Led sales and business development activities in 8 EU countries + Israel

    • Director, Brand Development
      Jan 2009 - Aug 2009 · 8 mos

      Responsibilities: branding strategies and brand name development, business development, market research, direct contact with senior executives in Pharmaceutical industries (Novartis, Merck Serono, Sanofi-Aventis, NovoNordisk …)

  • Aardex Group (2 yrs 6 mos)
    • EMEA Product Manager
      Sep 2007 - Dec 2008 · 1 yr 4 mos

      Designed and implemented, with affiliates, 3 adherence programs in oncology on local markets with Astra Zeneca and Novartis Led 3 global adherence initiatives with Abbott in HIV, Amgen in chronic kidney disease and Pfizer in osteoarthritis

    • Sales & Marketing Manager
      Jul 2006 - Sep 2007 · 1 yr 3 mos

      Pre-launch and launch of medAmigo program in Europe